FLXN

FLXN

Last Updated:

Q2 '20

Flexion

Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis.

Cash

$200.7M

Burn Rate (Qtr)

$141.2M

Pipeline Information

Click drug data to see upcoming trial info and prior data

Drug | Disease

Stage | Exp Date

Prior Data

Zilretta

osteoarthritis pain of the knee

Approved

February 28, 2021 (Est.)

ZILRETTA®

Osteoarthritis Knee Pain

Quarterly Sales (Approved)

March 12, 2021 (Est)

Recent Posts

See What The Community Is Saying - Click To See Full Post

FLXN - Flexion Therapeutics Re...

Summary: Company reported ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) net sales of $23.7 million in third quarter 2020
#FLXN reported financial results and recent busi...

Will FLXN stock pop in 2020?...

We were excited in mid-2019 about FLXN when sales of its osteoarthritis knee pain med, ZILRETTA, showed strong quarterly growth. Unfortunately, FLXN's valuation is down 25% in 2020. Find out why by c...

FLXN - Q2 2020 ZILRETTA® Net S...

#FLXN announced their Q2 2020 #ZILRETTA® net product sales of $15.5 million. See our AmpCard for details. #FLXN, #ZILRETTA, #triamcinolone_acetonide, #OA, #knee_pain...

FLXN's Preliminary Q2 ZILRETTA...

Flexion Therapeutics reported ZILRETTA (triamcinolone acetonide extended-release injectable suspension) preliminary net sales of $15.4 million in the second quarter. Flexion expects to report its com...

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon